CAS RN: 17965-75-2
3,8-dibromo[1,6]naphthyridine
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: ≥97%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 17965-75-2
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
≥97% |
5
In Stock
|
Beijing |
Inquiry |
| 0.25g |
≥97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 1g |
≥97% |
1
In Stock
|
Beijing |
Inquiry |
17965-75-2 / 3,8-dibromo-1,6-naphthyridine
Standard CAS: 17965-75-2
Multi CAS: No
Basic Information
CAS
17965-75-2
Multi CAS
No
Molecular Formula
C8H4Br2N2
Molecular Weight
287.940000
Exact Mass
287.872070
SMILES
C1=C2C=NC=C(C2=NC=C1Br)Br
InChI
InChI=1S/C8H4Br2N2/c9-6-1-5-2-11-4-7(10)8(5)12-3-6/h1-4H
InChIKey
XGNQDLUHEFXGPL-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
12
Aromatic heavy atom count
10
H-bond acceptors
2
Molar refractivity
54.94
TPSA
25.78
LogP / Solubility
WLOGP
3.15
MLOGP
2.79
XLogP3
2.5
Consensus LogP
2.81
Log S (ESOL)
-4.23
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.2
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.15
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.24
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
1.5